FindTrial
Sign In

Insulin resistance and obesity in adolescents - metabolic characterisation and effects of therapeutic intervention with metformin

Insulin resistance and obesity in adolescents - metabolic characterisation and effects of therapeutic intervention with metformin

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN43267711
Enrollment
Unknown
Registered
2005-01-13
Start date
2005-01-01
Completion date
Unknown
Last updated
2021-01-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Insulin resistance and obesity Nutritional, Metabolic, Endocrine Diabetes

Interventions

Metformin vs placebo (crossover design)

Sponsors

The Children's Hospital, Westmead - Research and Development Office (Australia)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Children and adolescents age 9-18 with obesity and insulin resistance, pre-type 2 diabetes.

Exclusion criteria

Exclusion criteria: Not provided at time of registration

Design outcomes

Primary

MeasureTime frame
Not provided at time of registration—

Secondary

MeasureTime frame
Not provided at time of registration—

Countries

Australia

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026